05-05-2025 18:30 via medpagetoday.com

SPARTAN Trial: Sparsentan Moves Up to First-Line in IgA Nephropathy

(MedPage Today) -- A wave of new therapies is transforming care for glomerular diseases, and nowhere is the momentum faster than in immunoglobulin A (IgA) nephropathy. At the National Kidney Foundation (NKF) Spring Clinical Meeting, researchers...
Read more »

Medical Industry news



Early Rituximab Can Delay Need for Chemo in Follicular Lymphoma
Time to Drop Confirmatory Testing for Primary Aldosteronism?
One-Size-Fits-All Ranges May Be Misclassifying Thyroid Diseases
20 Attorneys General Ask Federal Judge to Reverse Deep Cuts to HHS
Paramagnetic Rim Lesions and Multiple Sclerosis
Who Are the Authors of the HHS Report on Gender Dysphoria?
Is Injection or Surgery Better for Mixed Urinary Incontinence?
Medical Training Lags in Developing Countries. Technology Can Change the Game.
Carpal Tunnel Syndrome: Does It Flag Oncoming Rheumatoid Arthritis?
Why Ask the Question if the Answer Won't Help?
Interventional Cardiology Frets Over Healthcare Policy Threats
Trump's First 100 Days: Gawande, Offit, Hotez, and Others Weigh In
High-Dose Aflibercept Linked to More Intraocular Inflammation in Real-World Data
A Community Rallied to Share Flu Shot Experiences. Then the Gov't Stopped the Study.
Desktop versie